These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6376110)
1. Metabolic activation and lung toxicity: a basis for cell-selective pulmonary damage by foreign chemicals. Boyd MR Environ Health Perspect; 1984 Apr; 55():47-51. PubMed ID: 6376110 [TBL] [Abstract][Full Text] [Related]
2. Metabolic activation as a basis for organ-selective toxicity. Boyd MR; Grygiel JJ; Minchin RF Clin Exp Pharmacol Physiol; 1983; 10(1):87-99. PubMed ID: 6340874 [TBL] [Abstract][Full Text] [Related]
3. Morphological and biochemical correlates of chemical induced injury in the lung. A discussion. Smith LL; Cohen GM; Aldridge WN Arch Toxicol; 1986 Apr; 58(4):214-8. PubMed ID: 3521543 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary metabolism of foreign compounds: its role in metabolic activation. Cohen GM Environ Health Perspect; 1990 Apr; 85():31-41. PubMed ID: 2200668 [TBL] [Abstract][Full Text] [Related]
5. Biotransformation activities in Clara and alveolar type II cells isolated from hamster lungs. Myles JE; Geddes BA; Massey TE Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):297-309. PubMed ID: 2602659 [TBL] [Abstract][Full Text] [Related]
6. The role of metabolism in chemical-induced pulmonary toxicity. Smith BR; Brian WR Toxicol Pathol; 1991; 19(4 Pt 1):470-81. PubMed ID: 1813990 [TBL] [Abstract][Full Text] [Related]
7. Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins. Dinsdale D Int J Exp Pathol; 1995 Dec; 76(6):393-401. PubMed ID: 8652359 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of acute and chronic lung injury induced by foreign compounds. Witschi HP; Lindenschmidt RC Clin Physiol Biochem; 1985; 3(2-3):135-46. PubMed ID: 3891196 [TBL] [Abstract][Full Text] [Related]
9. In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. Devereux TR; Jones KG; Bend JR; Fouts JR; Statham CN; Boyd MR J Pharmacol Exp Ther; 1982 Jan; 220(1):223-7. PubMed ID: 7053419 [TBL] [Abstract][Full Text] [Related]
10. Alveolar type II and Clara cells: isolation and xenobiotic metabolism. Devereux TR Environ Health Perspect; 1984 Jun; 56():95-101. PubMed ID: 6383804 [TBL] [Abstract][Full Text] [Related]
11. Models and tools to study the biochemistry of toxic lung damage. Witschi H Rev Environ Health; 1975; 2(2):117-56. PubMed ID: 775573 [No Abstract] [Full Text] [Related]
12. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment. Kedderis GL; Lipscomb JC Toxicol Ind Health; 2001 Jun; 17(5-10):315-21. PubMed ID: 12539878 [TBL] [Abstract][Full Text] [Related]
13. Metabolic basis for the pulmonary Clara cell as a target for pulmonary carcinogenesis. Boyd MR; Reznik-Schüller HM Toxicol Pathol; 1984; 12(1):56-61. PubMed ID: 6387866 [TBL] [Abstract][Full Text] [Related]
14. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics. Philpot RM; Smith BR Environ Health Perspect; 1984 Apr; 55():359-67. PubMed ID: 6376107 [TBL] [Abstract][Full Text] [Related]
18. Metabolic activation and cytotoxicity of 4-ipomeanol in human non-small cell lung cancer lines. Falzon M; McMahon JB; Schuller HM; Boyd MR Cancer Res; 1986 Jul; 46(7):3484-9. PubMed ID: 3011249 [TBL] [Abstract][Full Text] [Related]
19. Freeze-etching electron microscopy of the lung. Lauweryns JM; Gombeer-Desmecht M Pathol Annu; 1973; 8():257-82. PubMed ID: 4355360 [No Abstract] [Full Text] [Related]
20. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Possible mechanisms of pulmonary pharmacotoxicity. Cooper JA; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Jul; 134(1):108-14. PubMed ID: 3014931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]